Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus

American Heart Journal

Volumn 137, Issue 5, 1999, Pages 949-957

  Kang, Xingping ^b   Berman, Daniel S ^a   Lewin, Howard ^b   Miranda, Romalisa ^b   Erel, Jacob ^b   Friedman, John D ^b   Amanullah, Aman M ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0032908837     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70421-7     Document Type: Article

References (36)

1. 1. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979;2:120-6.
2. 2. Bonow RO, Bohannon N, Hazzard W. Risk stratification in coronary artery disease and special populations. Am J Med 1996;101:4A17S-22S.
3. 3. The diabetes control and complications trial research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
4. 4. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44.
5. 5. Savage PJ. Cardiovascular complications of diabetes mellitus: what we know and what we need to know about their prevention. Ann Intern Med 1996;124(1 pt 2):123-6.
6. 6. Margolis JR, Kannel WS, Feinleib M, Dawber TR, McNamara PM. Clinical features of unrecognized myocardial infarction-silent and symptomatic: eighteen-year follow-up: the Framingham Study. Am J Cardiol 1973;32:1-7.
7. 7. Nesto RW, Phillips RT, Kett KG, Hill T, Perper E, Young E, Leland OS. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. Ann Intern Med 1988;108:170-5.
8. 8. Chiariello M, Indolfi C, Cotecchia MR, Sifola C, Romano M, Condorelli M. Asymptomatic transient ST changes during ambulatory ECG monitoring in diabetic patients. Am Heart J 1985;110:529-34.
9. 9. Zoneraich S, Silverman G, Zonersich O. Primary myocardial disease, diabetes mellitus, and small vessel disease. Am Heart J 1980;100:754-5.
10. 10. Pogatsa G, Koltai MZ, Koszeghy A, Ballagi-Pordany G, Balogh I. Influence of diabetic state on coronary vasoregulation in myocardial hyoxia. Biomed Biochem Acta 1988;47:279-84.
11. 11. Zatz R, Brenner BM. Pathogenesis of diabetic microangiopathy. The hemodynamic view. Am J Med 1986;80:443-53.
12. 12. Hasdai D, Gibbons RJ, Holmes DR, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997;96:3390-5.
13. 13. ACC/AHA Task Force. Guidelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Hear Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology. J Am Coll Cardiol 1995;25:521-47.
14. 14. Berman DS, Kiat H, Friedman JD, Wang FP, Van Train KF, Matzer L, et al. Separate acquisition rest thallium 201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993;22:1455-64.
15. 15. Diamond GA, Forrester JS. Analysis of probability as an aid to the clinical diagnosis of coronary artery disease. N Engl J Med 1979;300:1350-8.
16. 16. Diamond GA, Staniloff HM, Forrester JS, Pollock BH, Swan HJC. Computer assisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease. J Am Coll Cardiol 1983;1:444-55.
17. 17. Kiat H, Germano G, Friedman J, Van Train K, Silagan G, Wang FP, et al. Comparative feasibility of separate or simultaneous rest thallium-201/stress technetium-99m-sestamibi dual-isotope myocardial perfusion SPECT. J Nucl Med 1994;35:542-8.
18. 18. Matzer L, Kiat H, Wang FP, Van Train K, Germano G, Friedman J, et al. Pharmacologic stress dual-isotope myocardial perfusion single-photon emission computed tomography. Am Heart J 1994;128:1067-76.
19. 19. Amanullah A, Kiat H, Friedman JD, Berman DS. Adenosine technetium-99m sestamibi myocardial perfusion SPECT in women: diagnostic efficacy in detection of coronary artery disease. J Am Coll Cardiol 1996;27:803-9.
20. 20. Berman DS, Kiat H, Van Train K, Garcia E, Friedman J, Maddahi J. Technetium 99m sestamibi in the assessment of chronic coronary artery disease. Semi Nucl Med 1991;XXI:190-212.
21. 21. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico A, Friedman JD, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease. Circulation 1996;93:905-14.
22. 22. Ladenheim ML, Pollock BH, Rozanski A, Berman DS, Staniloff HM, Forrester JS, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986;7:464-71.
23. 23. Matzer L, Kiat H, Friedman J, Maddahi J, Berman D. A new approach to the assessment of tomographic thallium-201 in patients with left bundle branch block. J Am Coll Cardiol 1991;17:1309-17.
24. 24. Palmas W, Friedman JD, Diamond GA, Silber H, Kiat H, Berman DS. Incremental value of simultaneous assessment of myocardiol function and perfusion with technetium-99m sestamibi for prediction of extent of coronary artery disease. J Am Coll Cardiol 1995;25:1024-31.
25. 25. Van Train KF, Berman DS, Garcia EV, Berger HJ, Sands MJ, Friedman JD, et al. Quantitative analysis of stress thallium-201 myocardial scintigrams: a multicenter trial. J Nucl Med 1986;27:17-25.
26. 26. Berman DS, Kiat H, Maddahi J. The new 99m-Tc myocardial perfusion imaging agents: 99m-Tc-sestamibi and 99m-Tc-teboroxime. Circulation 1991;84 Suppl I:I-7-I-21.
27. 27. Bairey Merz CN, Berman DS. Imaging techniques for coronary artery disease: current status and future directions. Clin Cardiol 1997;20:526-32.
28. 28. Felsher J, Meissner MD, Hakki AH, Heo J, Kane-Marsch S, Iskandrian AS. Exercise thallium imaging in patients with diabetes mellitus. Arch Intern Med 1987;147:313-7.
29. 29. Blumenthal HT, Alex M, Golderberg S. A study of lesions of the intramural coronary artery branches in diabetes mellitus. Arch Pathol 1960;70:27-42.
30. 30. Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW. Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 1991;67:1073-8.
31. 31. Mahmarian JJ, Verani MS. Myocardial perfusion imaging during pharmacologic stress testing. Cardiol Clin 1994;12:223-45.
32. 32. Van Train KF, Garcia EV, Cooke D, Areeda J. Quantitative analysis of SPECT myocardial perfusion. In: Cardiac SPECT Imaging. New York: Raven Press; 1995. p. 49-74.
33. 33. Heo J, Powers J, Iskandrian AE. Exercise-rest same-day SPECT sestamibi imaging to detect coronary artery disease. J Nucl Med 1997;38:200-3.
34. 34. Rozanski A, Diamond GA, Berman D, Forrester JS, Morris D, Swan HJC. The declining specificity of exercise radionuclide ventriculography. N Engl J Med 1983;309:518-22.
35. 35. Rozanski A, Berman DS. The efficacy of cardiovascular nuclear medicine exercise studies. Semin Nucl Med 1987;17:104-20.
36. 36. Klein R, Klein BEK, Mass SE. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 1996;124(1 pt 2):90-6.